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Abstract: Objective:   A positron emission tomography (PET) scanner using a silicon
photomultiplier (SiPM PET) in place of a photomultiplier tube significantly improves the
spatial and time resolution. It may also improve the evaluation of smaller lesions
compared to conventional (non-SiPM) PET scanners. We compared the maximum
standardized uptake value (SUVmax), detection sensitivity, and morphological
correlation using magnetic resonance imaging (MRI) for primary tongue squamous cell
carcinoma between the SiPM PET and non-SiPM PET scanner.
Methods:   We retrospectively reviewed the F-18 fluorodeoxyglucose (FDG) PET/CT
features of tongue squamous cell carcinomas in consecutive, newly diagnosed, and
pathologically verified patients. Twenty-five of 46 patients were scanned using SiPM
PET scanner and the remaining 21 patients were scanned with a non-SiPM PET
scanner. We compared the SUVmax and visual evaluation of primary tumor
detectability, and the correlation between the PET-based and MRI-based tumor size
(long axis, thickness, and volume). Differences in SUVmax and detection sensitivity for
the primary tumor were analyzed using Welch’s  t  -test and Fisher’s exact test,
respectively. Correlations among the PET-based, MRI-based tumor size, and SUVmax
were assessed using Spearman’s rank correlation coefficient.
Results:   SUVmax of both T1/T2 and T3/T4 primary tumors were significantly higher
for the SiPM PET (T1/T2 mean SUVmax: 6.6 ± 4.3, T3/T4 mean SUVmax: 18.2 ± 9.8)
than that for the non-SiPM PET (T1/T2 mean SUVmax: 3.4 ± 1.4, T3/T4 mean
SUVmax: 10.2 ± 4.9) (P < 0.05). While all cases of T3/T4 primary tumors were
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
detected by both PET scanners, the detection sensitivity for T1/T2 primary tumors was
significantly higher for the SiPM PET (80%) than that for the non-SiPM PET (36.4%) (P
< 0.05). MRI-based tumor size correlated significantly with SiPM PET-based tumor
long axis (ρ = 0.74) and volume (ρ = 0.91), but not with the non-SiPM PET-based
tumor long axis and volume in T1/T2 primary lesions. Correlation between MRI-based
tumor size and SUVmax was significant in both PET scanners; however, no significant
difference was observed between the two scanners.
Conclusions   : The SiPM PET provides better detection sensitivity and a reliable
morphological correlation for the T1/T2 primary tongue tumors than the non-SiPM PET
due to its high performance.
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Abstract 
Objective: A positron emission tomography (PET) scanner using a silicon 
photomultiplier (SiPM PET) in place of a photomultiplier tube significantly improves 
the spatial and time resolution. It may also improve the evaluation of smaller lesions 
compared to conventional (non-SiPM) PET scanners. We compared the maximum 
standardized uptake value (SUVmax), detection sensitivity, and morphological 
correlation using magnetic resonance imaging (MRI) for primary tongue squamous cell 
carcinoma between the SiPM PET and non-SiPM PET scanner. 
Methods: We retrospectively reviewed the F-18 fluorodeoxyglucose (FDG) PET/CT 
features of tongue squamous cell carcinomas in consecutive, newly diagnosed, and 
pathologically verified patients. Twenty-five of 46 patients were scanned using SiPM 
PET scanner and the remaining 21 patients were scanned with a non-SiPM PET scanner. 
We compared the SUVmax and visual evaluation of primary tumor detectability, and the 
correlation between the PET-based and MRI-based tumor size (long axis, thickness, and 
volume). Differences in SUVmax and detection sensitivity for the primary tumor were 
analyzed using Welch’s t-test and Fisher’s exact test, respectively. Correlations among 
the PET-based, MRI-based tumor size, and SUVmax were assessed using Spearman’s 
rank correlation coefficient. 
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Results: SUVmax of both T1/T2 and T3/T4 primary tumors were significantly higher 
for the SiPM PET (T1/T2 mean SUVmax: 6.6 ± 4.3, T3/T4 mean SUVmax: 18.2 ± 9.8) 
than that for the non-SiPM PET (T1/T2 mean SUVmax: 3.4 ± 1.4, T3/T4 mean 
SUVmax: 10.2 ± 4.9) (P < 0.05). While all cases of T3/T4 primary tumors were 
detected by both PET scanners, the detection sensitivity for T1/T2 primary tumors was 
significantly higher for the SiPM PET (80%) than that for the non-SiPM PET (36.4%) 
(P < 0.05). MRI-based tumor size correlated significantly with SiPM PET-based tumor 
long axis (ρ = 0.74) and volume (ρ = 0.91), but not with the non-SiPM PET-based tumor 
long axis and volume in T1/T2 primary lesions. Correlation between MRI-based tumor 
size and SUVmax was significant in both PET scanners; however, no significant 
difference was observed between the two scanners. 
Conclusions: The SiPM PET provides better detection sensitivity and a reliable 
morphological correlation for the T1/T2 primary tongue tumors than the non-SiPM PET 
due to its high performance. 
 
Keywords: F-18 fluorodeoxyglucose PET/CT (F-18 FDG PET/CT), silicon 
photomultiplier, tongue cancer  
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Introduction 
In diagnostic imaging of primary malignant tumors, computed tomography (CT) and 
magnetic resonance imaging (MRI) are highly useful modalities for evaluating the size 
and extension of lesions. The evaluation of primary oral tumors on CT is often useless 
due to dental metal artifacts, and that on MRI is also sometimes difficult. F-18 
fluorodeoxyglucose (FDG) positron emission tomography/computed tomography 
(PET/CT) for primary lesions is particularly important for evaluating the tumor 
metabolic activity, determining the presence or absence of local recurrence after surgery, 
assessing the treatment effects of chemoradiotherapy, and prognosis prediction [1-5]. In 
oral cancer, interstitial brachytherapy is sometimes applied for T1-2 lesions, and 
superselective intra-arterial chemoradiotherapy is increasingly applied for advanced 
tumors as a definite treatment [6-8]. Therefore, it is important to evaluate the metabolic 
activity and tumor size on PET in order to determine the prognostic prediction, 
treatment effect, and presence or absence of local recurrence. In particular, it is essential 
to accurately evaluate the tumor activity and morphology on PET, even for a superficial 
and small lesion in case of the small recurrent tumor, tumor regressed by treatment, T1-
2 lesion, or useless on CT or MRI due to metal artifact. 
However, the FDG accumulation level is underestimated due to the partial-
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volume effect when the tumor is small; this is considered a disadvantage of the PET 
examination [9, 10]. The partial-volume effect typically occurs whenever a tumor size is 
less than approximately three times the spatial resolution, and smaller lesions are 
therefore evaluated as having a smaller standardized uptake value (SUV) [9]. The 
recovery coefficient (RC) for a 10 mm-diameter hot sphere (RC10 mm) filled with a 
radioisotope (RI) solution of our conventional PET/CT scanner, which is in use at our 
hospital, is 41%. That is, for lesions of 10 mm uptake size, the SUV is theoretically 41% 
of the true value. Primary tumors with small and superficial lesions are likely to be 
underestimated by PET. Thus, PET-based quantitative analysis of T1/T2 oral primary 
tumors, whose thickness is less than 10 mm, is not likely to be accurate. Therefore, 
many oral cancers go undetected and the maximum SUV (SUVmax) and size of the 
tumor is underestimated. 
A PET scanner using a silicon photomultiplier (SiPM) instead of a 
photomultiplier tube has recently been developed. Many technological improvements of 
this new PET system have been made, in terms of both hardware and software, resulting 
in better imaging quality, higher spatial resolution, and more accurate image 
reconstruction [11, 12]. The RC10 mm of the PET scanner using the SiPM at our hospital is 
71%, which is far superior to the RC10 mm of a conventional PET (41%). On the other hand, 
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the RC for > 20-mm-diameter hot sphere of a RI is almost 100% for both the SiPM and 
conventional PET scanners. Therefore, the PET scanner using SiPM with improved 
quantitative ability for small objects can be expected to be more sensitive than the 
conventional PET scanners for the detection of small lesions [13]. Moreover, the SiPM 
PET should be able to accurately evaluate the tumor activity and morphology, such as the 
tumor length, thickness, and volume for primary oral tumors as most of them are 
small/superficial tumors such as the T1/T2 lesions. Herein, we compared the detection 
sensitivity, SUVmax, and the correlation between PET-based and MRI-based 
morphological size of the primary tongue tumors determined by the PET scanner using 
SiPM (SiPM PET) and by a conventional PET scanner (non-SiPM PET). 
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Materials and methods 
We performed this study in accordance with the Declaration of Helsinki. Informed 
consent was obtained from all individual participants included in the study. The relevant 
institutional review board approved this retrospective study (No. 2017-3-34). 
Patients 
We retrospectively reviewed 49 consecutive patients, newly diagnosed with a tongue 
squamous cell carcinoma. They all underwent F-18 FDG-PET/CT, ultrasonography 
(USG), and contrast-enhanced MRI for cancer staging before treatment, between 
October 2016 and January 2019. These cases were all confirmed by pathological 
diagnosis. We excluded three of 49 patients because of a biopsy performed within a 
week before these imaging examinations and enrolled the remaining 46 patients in this 
study (26 men, 20 women; age range, 21–94 years; mean age, 65.9 years). We 
investigated the primary tumor classification, diameter, thickness, and histopathological 
grade to evaluate bias between the cases scanned with SiPM and non-SiPM PET. The 
clinical T category (cT) was determined according to the eighth edition of the TNM 
classification of malignant tumors edited by the Union for International Cancer Control 
[14]. We defined the tumor diameter as the maximum size in the axial or coronal plane 
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on an MRI. We prioritized the USG measurements in tumor thickness for determining 
the cT stage. We investigated the histopathological grade of the mode of invasion by 
using the modified Jakobsson criteria [15, 16], and the degree of differentiation using 
the WHO classification of tumor malignancy gradation [17]. Pathological tumor size 
(tumor long axis and tumor thickness from the tongue surface) was investigated except 
for the 16 cases in which the measurements could not be performed pathologically. 
Imaging technique 
Twenty-five of 46 patients were imaged using a SiPM PET/CT scanner (Discovery MI, 
GE Healthcare, Fairfield, US), and the remaining 21 patients by a conventional PET/CT 
scanner (TruePoint Biograph 40, Siemens Medical Solutions, Erlangen, Germany). The 
SiPM or non-SiPM PET examination was randomly selected for each patient. After a 4-
hour fast, the patients were injected with 3.7 MBq (0.1 mCi) F-18 FDG/kg body weight. 
All patients required a blood glucose level of < 200 mg/dl before the FDG injection. 
One hour after the injection, a spiral CT scan was performed using 60–100 mAs 
(automatic exposure control), 120 kVp, and 3.75-mm slice thickness in the SiPM 
PET/CT scanner, or 25 effective mAs, 130 kVp, and 5-mm slice thickness in the non-
SiPM PET/CT scanner, followed by a PET scan from the distal femur to the top of the 
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skull. A SiPM PET scan was performed using a 2-min scanning time per bed position, 
increments of 19.5 cm (3D mode), and seven bed-positions. A non-SiPM PET scan was 
performed using a 2-min scanning time per bed position, increments of 16.2 cm (3D 
mode), and eight bed-positions. The SiPM PET images were reconstructed using the 
newly developed algorithms (block sequential regularized expectation maximization, β 
= 600) to a final pixel size of 3.6 mm × 3.6 mm × 2.7 mm. The non-SiPM PET images 
were reconstructed using the iterative algorithms (ordered-subset expectation 
maximization, four iterations, and 21 subsets) to a final pixel size of 4.1 mm × 4.1 mm 
× 2.0 mm. An 8-mm full-width at half-maximum Gaussian filter was applied after the 
reconstruction. 
MRI examinations were performed using a 1.5T MR imager (Achieva 1.5T 
Nova Dual, Philips Medical Systems, Eindhoven, Netherlands) or a 3.0T MR imager 
(Achieva 3.0T dStream or Ingenia 3.0T CX, Philips Medical Systems, Eindhoven, 
Netherlands) with the head and neck coil. MRI protocols are as follows: transverse fat-
suppressed T2-weighted images (3500–5000/49–90 [repetition time msec/echo time 
msec], field of view 230–250 mm, acquisition matrix 256  256, 320  320, 400  400, 
and section thickness 5 mm), transverse fat-suppressed postcontrast T1-weighted 
images (538–783/8–10, field of view 230–250 mm, acquisition matrix 320  320, 504  
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504, 548  548, and section thickness 5–7 mm) with an intravenous infusion of 0.2 
ml/kg body weight gadolinium contrast agents (Magnescope, meglumine gadoterate, 
Guerbet Japan, Tokyo, Japan; Gadovist, Gadobutrol, Bayer HealthCare, Berlin, 
Germany). 
Image analysis 
Board-certified oral and maxillofacial radiologists (MI and MS, with 24 and 36 years of 
experience, respectively) independently reviewed the randomly ordered PET images, 
while being blinded to all clinical information other than that the PET images were 
obtained from patients with a tongue tumor. The reviewers visually evaluated the 
presence or absence of an abnormal FDG accumulation suspected of representing the 
primary tongue tumor, both on pre- and post-attenuation corrected PET images. 
Reviewers resolved disagreements in assessment by discussion. Another board-certified 
oral and maxillofacial radiologist (IK with 16 years of experience), who knew the site of 
the primary tumors, reviewed the randomly ordered PET images and measured the 
SUVmax, morphological tumor size: long axis (the length in the transverse plane), 
thickness (depth from tongue surface in the transverse plane), and the volume of the 
primary tumor while taking care to avoid the high physiological accumulation areas 
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other than the tumor. The reviewer also reviewed the randomly ordered MRI and 
measured the same morphological tumor sizes (long axis, thickness, and volume) on the 
transverse fat-suppressed T2-weighted images or transverse fat-suppressed postcontrast 
T1-weighted images. The measurements of tumor volume were calculated as the sum of 
all transverse section areas, multiplied by the section thickness, as previously reported 
[18]. 
Statistical analysis 
Detection sensitivity for the primary tumor, sex ratio, and T category ratio was 
compared between the groups, examined by SiPM PET or non-SiPM PET scanner, by 
using the Fisher’s exact test. Welch’s t-test was used to analyze the differences in the 
SUVmax and mean age of patients between the two groups. The Mann–Whitney U-test 
was used to analyze the differences in the histological grade (mode of invasion and 
degree of differentiation) and tumor morphology (major axis, thickness, and volume) 
between the two groups. Correlations among the PET-based, MRI-based, pathological 
tumor sizes, and SUVmax were tested by Spearman’s rank correlation coefficient (ρ). 
The strength of correlation was classified as negligible or no correlation (|ρ| ≤ 0.20), 
weak (|ρ| = 0.21 to 0.40), moderate (|ρ| = 0.41 to 0.70), or strong (|ρ| = 0.71 to 1.00). All 
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p-values were two-sided and p-values of < 0.05 were considered statistically significant.
For statistical analysis, we used the EZR software (Saitama Medical Center, Jichi 
Medical University), which provides a graphical interface for R (version 3.2.2; The R 
Foundation for Statistical Computing, Vienna, Austria). 
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Results 
Characteristics of patients and primary tumors 
The mean age of the patients examined by SiPM PET was 66.1 ± 19.4 years, and that of 
those examined by non-SiPM PET was 65.6 ± 10 years. Of the 25 primary tumors 
examined by SiPM PET, six were clinically diagnosed as being T1 tumors, nine were 
T2 tumors, six were T3 tumors, and four were T4 tumors. Of the 21 primary tumors 
examined by non-SiPM PET, three were clinically diagnosed as T1 tumors, eight were 
T2 tumors, five were T3 tumors, and five were T4 tumors. No tumor was 
histopathologically upgraded in the clinical T category of the TNM classification. There 
were no significant differences in the primary tumor volume, major axis, thickness, the 
histopathological grade of the mode of invasion, and the degree of differentiation 
between the patients examined by the two types of PET scanners. No significant 
differences were found between the two groups in other histological parameters, i.e., 
microvascular invasion, perineural invasion, and lymphatic vascular invasion (data not 
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Many cases of T1/T2 primary tumors were detectable by the SiPM PET but not by the 
non-SiPM PET (Figure 1). All cases of T3/T4 primary tumors were detectable by both 
the SiPM PET and non-SiPM PET (Figure 2). The detection sensitivity for T1/T2 
primary tumors was 80% by SiPM PET and 36.4% by non-SiPM PET. The detection 
sensitivity for T1/T2 primary tumors was therefore significantly higher with the SiPM 
PET than that with the non-SiPM PET (P < 0.05) (Figure 3a). For T3/T4 primary 
tumors, detection sensitivity was 100% by both the PET scanners (Figure 3b). The 
SUVmax of the T1/T2 primary tumors was 6.6 ± 4.3 in the SiPM PET and 3.4 ± 1.4 in 
the non-SiPM PET groups. Thus, the SUVmax of the T1/T2 primary tumors was 
significantly higher in the SiPM PET than that in the non-SiPM PET group (P < 0.05) 
(Figure 3c). The SUVmax of the T3/T4 primary tumors was 18.2 ± 9.8 in the SiPM 
PET and 10.2 ± 4.9 in the non-SiPM PET group. Thus, the SUVmax of the T3/T4 
primary tumors was also significantly higher in the SiPM PET than that in the non-
SiPM PET group (P < 0.05) (Figure 3d). 
Correlation between PET and other parameters 
The pathological tumor size was significantly correlated with the MRI-based (ρ =0.74 
and 0.88) and the SiPM PET-based (ρ = 0.65 and 0.81) tumor size (long axis and 
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thickness, respectively), and the non-SiPM PET-based tumor thickness (ρ =0.69), but 
not with the non-SiPM PET-based long axis (Figure 4a-f). These ρ values between the 
pathological and MRI-based long axis and thickness, and between the pathological and 
SiPM PET-based thickness, exhibited a strong correlation. 
MRI-based tumor long axis and volume were significantly correlated with the 
SiPM PET-based long axis and volume (long axis: ρ =0.74, volume: ρ =0.91), but not 
with the non-SiPM PET-based tumor long axis and volume in the T1/T2 primary lesions 
(Figure 5a, 5b, 5e, and 5f). Both ρ values exhibited a strong correlation. MRI-based 
tumor thickness was not correlated with both the SiPM and non-SiPM PET-based 
thickness in the T1/T2 primary lesions (Figure 5c and 5d). In T3/T4 lesions, MRI-
based tumor size (long axis, thickness, and volume) were all significantly correlated 
with both the SiPM PET-based (long axis: ρ =0.65, thickness: ρ =0.80, volume: ρ 
=0.95) and the non-SiPM PET-based (long axis: ρ =0.68, thickness: ρ =0.77, volume: 
ρ =0.97) tumor size (data not shown). 
MRI-based tumor sizes (long axis, thickness, and volume) were all 
significantly correlated with the SUVmax in both the SiPM (long axis: ρ =0.73, 
thickness: ρ =0.76, volume: ρ =0.77) and non-SiPM PET (long axis: ρ =0.55, 
thickness: ρ =0.75, volume: ρ =0.76) (Figure 6a-f). These ρ values exhibited a strong 
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correlation except for a moderate correlation between the MRI-based long axis and 
SUVmax in non-SiPM PET. 
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Discussion 
In this study, we analyzed the detection sensitivity for primary tongue tumors of a SiPM 
PET scanner in comparison with the conventional non-SiPM PET scanner. The SiPM 
PET scanner demonstrated better imaging quality, higher spatial resolution, and more 
accurate imaging reconstruction than the conventional PET scanner. The detection 
sensitivity for T1/T2 primary tumors was significantly higher for the SiPM PET than 
that for the non-SiPM PET scanner, while both types of scanners could detect the T3/T4 
primary tumors. The SUVmax for all T-stages of primary tumors was significantly 
higher for the SiPM PET than that for the non-SiPM PET scanner, and the SiPM PET-
based tumor size had a stronger significant correlation with the pathological and MRI-
based tumor size than the non-SiPM PET-based tumor size.
The SUVmax of T1/T2 tumors in the SiPM PET was about twice of that in the 
non-SiPM PET (Figure 3c). The difference in the SUVmax suggests that non-SiPM 
PET underestimates the quantification of primary tumors, whereas the SiPM PET 
performs a more accurate quantitative evaluation. Differences in the scanner 
performance in terms of radiation sensitivity, spatial resolution, and imaging 
reconstruction influence the SUV quantitative ability. Roncali et al. [11] reported that 
the PET scanner using SiPM has significantly improved radiation sensitivity, spatial 
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resolution, and imaging reconstruction. Teo et al. [10] reported that SiPM PET had 
improved SUV quantitative ability for small objects, both in phantoms and the patients. 
In patients who had undergone both the SiPM PET and non-SiPM PET examinations, 
SUVmax of the various accumulations, such as physiological and pathological 
accumulation, was higher in the SiPM PET than that in the non-SiPM PET [13]. Baratto 
et al. [13] compared the SUVmax of various lesions between the SiPM and non-SiPM 
PET and found that the SUVmax was higher for the SiPM PET. The RC10 mm, which is 
affected by the spatial resolution, was 71% in our SiPM PET scanner, which was far 
superior to the RC10 mm of 41% of our hospital’s non-SiPM PET scanner. Thus, in 
accordance with the previous reports, our study demonstrated that the high SUVmax of 
primary T1/T2 tongue tumors is likely to exhibit a more accurate quantitative ability of 
SiPM PET due to the high performance of the scanner in terms of spatial resolution. On 
the other hand, the SUVmax of T3/T4 tumors was also significantly higher in the SiPM 
PET than that in the non-SiPM PET (Figure 3d). Since the RC for > 20-mm-diameter 
hot sphere of an RI is almost 100% for both the SiPM and non-SiPM PET scanners, it is 
reasonable to consider that the difference of metabolic activity is highly likely to 
significantly influence the SUVmax of the T3/T4 tumors rather than the difference of 
the scanner’s performance. The expression of the glucose transporters, Glut1 and Glut4, 
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which are key regulators of F-18 FDG, highly influence the SUVmax. We should have 
analyzed the expression of the Glut1 and Glut4 using immunohistology or quantitative 
PCR but were unable to perform such analyses in our retrospective study. Thus, the 
biological aspect is a major limitation of this study. Furthermore, we should design a 
prospective study that performs consecutive SiPM and non-SiPM PET for the same 
lesion to avoid the tumor metabolic differences in a future study. 
The detection sensitivity for T1/T2 primary tongue tumors by the SiPM PET 
was more than two-fold than that of the non-SiPM PET. We demonstrated that SiPM 
PET was significantly better than the non-SiPM PET for the detection of T1/T2 primary 
tongue tumors (Figure 3a). The detection sensitivity for T3/T4 primary tumors was 
100% for both the PET scanners (Figure 3b). These results showed that the SiPM PET 
had a higher detection sensitivity than the non-SiPM PET for smaller tongue tumors. 
Yamazaki et al. [19] reported that FDG-PET exhibited a 100% detection sensitivity for 
metastatic lymph nodes that had a short-axis diameter of more than 10 mm, but did not 
detect those smaller than 5 mm. Our study demonstrated an improved sensitivity of 
SiPM PET for detecting primary tumors that are less than 5 mm thickness, which has 
not been directly shown in previous studies. 
The significant correlation between the pathological and SiPM PET-based 
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tumor thickness (ρ = 0.81) was stronger than that between the pathological and non-
SiPM PET-based thickness (ρ =0.69) (Figure 4d and 4f). The pathological long axis 
significantly correlated with the SiPM PET-based long axis (ρ = 0.65), but not with the 
non-SiPM PET-based long axis (Figure 4c and 4e). Moreover, MRI-based tumor size, 
which had an extremely strong correlation with the pathological tumor size (long axis: ρ 
=0.74, thickness: ρ =0.88) (Figure 4a and 4b), was significantly correlated with the 
SiPM PET-based tumor size (long axis: ρ =0.74, volume: ρ =0.91) but not with non-
SiPM PET-based tumor long axis and volume in the T1/T2 primary lesions (Figure 5a, 
5b, 5e, and 5f). Yu et al. [20] reported that the tumor size (X-, Y-, Z-axis) measured on 
FDG PET/CT correlated more reliably with the pathological findings than that on a CT. 
Koopman et al. [21] and Nguyen et al. [22] prospectively evaluated the performance of 
a SiPM PET in patients with various cancer compared to a non-SiPM PET and 
demonstrated that the SiPM PET-based tumor volume significantly decreased by 13-
30%, compared to the non-SiPM PET. They suggest that these decreases in tumor 
volume were likely caused by the higher resolution of the SiPM PET system that 
decreases the partial-volume effect. Similar to these three studies, our result showed that 
the non-SiPM PET-based tumor size tended to increase in the T3/T4 lesions (data not 
shown). Moreover, non-SiPM PET-based volume decreased due to the underestimation 
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of the FDG uptake and did not correlate with the MRI-based tumor volume in the T1/T2 
lesions (Figure 5f). In contrast, SiPM PET strongly correlated with the MRI-based 
tumor volume, even small and superficial tumors. These results were largely due to the 
high performance of the SiPM PET scanner. Thus, SiPM PET had a more reliable 
morphological correlation for T1/T2 primary tongue tumors than the non-SiPM PET. 
The tumor volume used for treatment effect and prognosis prediction had a particularly 
high correlation between the SiPM PET-based and MRI-based volume (ρ =0.91) and 
SiPM PET may be useful for the evaluation in those treatment planning based on both 
the metabolic and morphological aspects. 
MRI-based tumor size (long axis, thickness, and volume) were all significantly 
correlated with the SUVmax in both the SiPM (long axis: ρ =0.73, thickness: ρ =0.76, 
volume: ρ =0.77) and non-SiPM PET (long axis: ρ =0.55, thickness: ρ =0.75, volume: 
ρ =0.76) (Figure 6a-f). These results were similar to the linear proportional 
relationship between the RC and the sphere diameter [10] and demonstrated that the 
SUVmax tended to increase with the tumor size (long axis, thickness, and volume) in 
the tongue primary tumor. However, unlike the RC measured by a phantom, tumor 
SUVs exhibited different values depending on their biological activity. Therefore, this 
correlation data may be the result of confusion between the scanner performance and 
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biological activity. No significant difference may exist in the correlation coefficient 
between the two scanners due to the influence of the biological activity, similar to the 
limitation mentioned before. 
As a limitation of this study and as a consideration for future research, 
the effects of metal artifacts on PET images were not taken into account in this study. In 
general, X-ray attenuation correction based on CT is difficult when metal artifacts 
occur. It has been pointed out that CT-based attenuation correction results in 
overestimation of tracer accumulation in the areas corresponding to bright streak 
artifacts on CT images [23-25]. Shimamoto et al. [25] also reported that underestimation 
might occur due to a decrease in radiation sensitivity when the tumor was in contact 
with a dental metal prostheses. We were able to prevent the overestimation of the tracer 
accumulation entirely by inspecting both attenuation correction and non-attenuation 
correction PET images in our research, as recommended by Shimamoto et al. [25]. On 
the other hand, underestimation of the lesions around dental metal prostheses should be 
taken into consideration. In our study, because there was no bias in the amount of metal 
artifact between the two groups and the availability of tumor detection, the metal 
artifacts had little impact on our results. However, it may be necessary to conduct a 
more detailed investigation using a phantom to ascertain the effects of metal artifacts. 
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Additionally, it will be necessary to examine other oral cancers with a more complicated 
anatomy, which cannot be expressed in a simple manner in terms of diameter in the oral 
cavity. In future, the goal is to apply this high-resolution PET scanner to the evaluation 
of tumor activity and prognosis prediction, and thereby contribute to treatment decision. 
Another major limitation of this study is that we did not consider the motion 
artifact of the tongue. In an MRI study, where the scan times were similar to that of 
PET, Suzuki et al. [26] investigated the influence of the motion artifact on tongue 
morphological size. They concluded that wearing dentures during an MRI examination 
reduces the motion artifacts in edentulous patients without any occlusal support. 
Although we could not analyze the presence or absence of the occlusal support in the 
patients of the present study, we believe that motion artifacts are greatly related to 
individual differences other than occlusal support. On the other hand, although the 
tumors shrink during the surgical excision and fixation in buffered formalin, MRI-based 
tumor size has demonstrated a marked correlation with the histopathological thickness 
in several reports [27-31]. Since MRI and PET may, on occasion, over-estimate the 
tumor size in cases of recent biopsy and inflammation, we excluded the three patients 
who had undergone biopsy within a week before these imaging examinations. As a 
result, the correlation between the pathological and MRI-based tumor size was 
23 
Semiconductor PET of tongue cancer 
extremely strong. The correlation between the MRI-based and PET-based tumor size 
was also strong in the present study. Consequently, although the influence of motion 
artifacts cannot be ruled out, the morphological measurement and correlation of the 
tongue tumor are likely to be highly reliable. 
Conclusion 
The SiPM PET demonstrated superior detection sensitivity and more reliable 
morphological correlation for the T1/T2 primary tongue tumors than the non-SiPM 
PET, due to the high performance of the scanner. 
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Figure Legends 
Figure 1 
T1 tumor cases examined by the SiPM PET (a–c) and non-SiPM PET (d-f). The 
macroscopic finding shows a T1 tumor in the right (a) or left (d) lateral tongue. Post-
contrast T1-weighted image depicts the T1 tumor in both cases (b: major axis 12 mm, 
thickness 4 mm; d: major axis 17 mm, thickness 4 mm). SiPM PET (c) detected the T1 
tumor whereas non-SiPM PET (f) could hardly detect it. SiPM = silicon 
photomultiplier, SUVmax = maximum standardized uptake value. 
Figure 2 
T3 tumor cases examined by the SiPM PET (a–c) and non-SiPM PET (d–f). Post-
contract T1-weighted image depicts the T3 tumor in both cases (a, b: major axis 31 mm, 
thickness 17 mm; d, e: major axis 31 mm, thickness 17 mm). SiPM PET (c) and non-
SiPM PET (f), both detected the T3 tumors. SiPM = silicon photomultiplier, SUVmax = 
maximum standardized uptake value. 
Figure 3 
Detection sensitivity of T1/T2 (a) and T3/T4 (b) primary tumors in SiPM PET and non-
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SiPM PET. Mean SUVmax of T1/T2 (c) and T3/T4 (d) primary tumor in SiPM PET and 
non-SiPM PET. SUVmax = maximum standardized uptake value, SiPM = silicon 
photomultiplier. N.S. = not significant. Fisher’s exact test: †P < 0.05. Welch’s t-test: ‡P 
< 0.05. 
Figure 4 
Correlation between the pathological and the MRI-based or PET-based tumor size. The 
correlation between the pathological and MRI-based long axis (a), pathological and 
MRI-based thickness (b), pathological and SiPM PET-based long axis (c), pathological 
and SiPM PET-based thickness (d), pathological and non-SiPM PET-based long axis 
(e), and pathological and non-SiPM PET-based thickness (f). SiPM = silicon 
photomultiplier. N.S. = not significant. Spearman's rank correlation coefficient (ρ) test: 
*p < 0.05, **p < 0.01, ***p < 0.001
Figure 5 
Correlation between the MRI-based and PET-based tumor size in the T1/T2 lesions. The 
correlation between the MRI-based and SiPM PET-based long axis (a), MRI-based and 
non-SiPM PET-based long axis (b), MRI-based and SiPM PET-based thickness (c), 
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MRI-based and non-SiPM PET-based thickness (d), MRI-based and SiPM PET-based 
volume (e), and MRI-based and non-SiPM PET-based volume (f). SiPM = silicon 
photomultiplier, N.S. = not significant. Spearman's rank correlation coefficient (ρ) test: 
**p < 0.01, ***p < 0.001 
Figure 6 
Correlation between the MRI-based tumor size and SUVmax. The correlation between 
the MRI-based long axis and SUVmax in the SiPM PET (a), MRI-based long axis and 
SUVmax in the non-SiPM PET (b), MRI-based thickness and SUVmax in the SiPM 
PET (c), MRI-based thickness and SUVmax in the non-SiPM PET (d), MRI-based 
volume and SUVmax in the SiPM PET (e), and MRI-based volume and SUVmax in the 
non-SiPM PET (f). SUVmax = maximum standardized uptake value, SiPM = silicon 
photomultiplier. Spearman's rank correlation coefficient (ρ) test: *p < 0.05, **p < 0.01, 
***p < 0.001 
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Table 1. Clinical Characteristics of Study Population 
SiPM = silicon photomultiplier. Mode of invasion: modified Jakobsson criteria, Degree of 
differentiation: WHO classification of tumor malignancy gradation. †Fisher’s exact test, 
‡Welch’s t-test, #Mann–Whitney U test, N.S.: not significant. Data are presented as mean ± 
standard deviation, median [interquartile rage] or number, as appropriate. 
SiPM PET non–SiPM PET 
Characteristics 
of patients 
Number of patients 25 21 
Male:Female 12:13 14:7 †N.S. 
Mean age (years) 66.1 ± 19.4 65.6 ± 10 ‡N.S. 
T category 
T1 6 3 
†N.S. 
T2 9 8 
T3 6 5 
T4 4 5 
T1/T2 
morphology 
Major axis (mm) 17.2 [13.0–19.6] 20.3 [18.3–22.8] #N.S. 
Thickness (mm) 3.5 [2.7–4.4] 5.5 [3.6–7.2] #N.S. 
Volume (cm3) 0.48 [0.18–1.02] 0.57 [0.38–1.27] #N.S. 
T1/T2 
histopathology 
Mode of invasion 3 [2–3] 3 [2–3] #N.S. 
Degree of differentiation 1 [1–1] 1 [1–1] #N.S. 
T3/T4 
morphology 
Major axis (mm) 36.1 [30.5–39.3] 31.2 [26.4–42.7] #N.S. 
Thickness (mm) 15.1 [12.5–22.9] 11.8 [10.9–26.0] #N.S. 
Volume (cm3) 10.6 [7.0–15.6] 5.41 [3.14–26.6] #N.S. 
T3/T4 
histopathology 
Mode of invasion 2 [2–3] 3 [3–3.25] #N.S. 
Degree of differentiation 1 [1–1] 1 [1–1] #N.S. 
Table 1
